Phase forward announces $25 million share repurchase program (business wire via yahoo! finance)

2010-02-17 | Source

WALTHAM, Mass.----Phase Forward Incorporated , a leading provider of data management solutions for clinical trials and drug safety, announced today that its board of directors has authorized the repurchase of an additional $25.0 million of its common stock, to be completed by December 31, 2010.